Lam Research Corporation $LRCX Shares Purchased by NZS Capital LLC

NZS Capital LLC boosted its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 1.5% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,071,186 shares of the semiconductor company’s stock after acquiring an additional 16,308 shares during the quarter. Lam Research comprises 4.4% of NZS Capital LLC’s holdings, making the stock its 3rd biggest position. NZS Capital LLC’s holdings in Lam Research were worth $143,432,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in LRCX. Howard Hughes Medical Institute purchased a new position in shares of Lam Research during the second quarter worth approximately $27,000. Sound Income Strategies LLC acquired a new stake in Lam Research during the 3rd quarter worth $41,000. Tripletail Wealth Management LLC purchased a new position in Lam Research during the 3rd quarter worth $44,000. Strategic Wealth Investment Group LLC acquired a new position in Lam Research in the second quarter valued at $29,000. Finally, Delos Wealth Advisors LLC acquired a new position in Lam Research in the second quarter valued at $30,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Insider Activity

In other news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the sale, the director owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ava Harter sold 4,000 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.50, for a total value of $930,000.00. Following the completion of the sale, the insider owned 54,705 shares in the company, valued at approximately $12,718,912.50. This represents a 6.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 79,329 shares of company stock worth $18,110,542. Company insiders own 0.31% of the company’s stock.

Lam Research Trading Down 5.9%

Shares of LRCX stock opened at $217.27 on Wednesday. The business’s fifty day moving average price is $218.86 and its 200 day moving average price is $167.34. The firm has a market capitalization of $271.32 billion, a PE ratio of 44.52, a P/E/G ratio of 2.49 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61. Lam Research Corporation has a 1-year low of $56.32 and a 1-year high of $256.68.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The company had revenue of $5.34 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the firm earned $0.91 EPS. The business’s revenue was up 22.1% on a year-over-year basis. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, sell-side analysts forecast that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be issued a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, March 4th. This represents a $1.04 dividend on an annualized basis and a yield of 0.5%. Lam Research’s dividend payout ratio (DPR) is 21.31%.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam’s latest quarterly results and guidance remain supportive: the company beat EPS and revenue estimates last quarter and issued FY guidance that keeps the multi-quarter recovery narrative intact — a key reason many analysts remain constructive on the name. (Earnings/guidance from company filings and recent earnings release)
• Positive Sentiment: Coverage and analyst sentiment emphasize Lam’s outperformance versus semiconductor peers over the past year, helping underpin investor confidence in the stock’s secular positioning. How Is Lam Research’s Stock Performance Compared to Other Semiconductor Stocks?
• Positive Sentiment: Long-term bullish research highlights Lam as a core pick for investors focused on secular demand in logic and foundry tooling, reinforcing buy-and-hold interest. Why Lam Research (LRCX) is a Top Stock for the Long-Term
• Neutral Sentiment: Management presented at the Morgan Stanley TMT conference; presentations can reaffirm execution plans and demand cadence but did not disclose material new guidance that would immediately change the outlook. Investors will parse the transcript for color on order trends and capex timing. Lam Research Corporation (LRCX) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
• Neutral Sentiment: Technical/commentary pieces suggest potential for further upside in the near term (price targets cited), but these are speculative and may amplify intraday volatility rather than change fundamentals. Lam Research (LRCX) Favors Final Push In To $262.9 – $280.8 Before Pullback
• Negative Sentiment: Insider selling: the CFO sold ~40,329 shares (~$9.3M) and another insider sold 4,000 shares (~$0.93M) in early March. Large, contemporaneous insider sales can spark short-term selling pressure and investor concern, even when insiders retain substantial positions. CFO Form 4 (SEC)
• Negative Sentiment: Near-term performance data show the stock underperformed peers on Monday, which can trigger algorithmic and momentum selling into weakness. Lam Research Corp. stock underperforms Monday when compared to competitors

Analyst Ratings Changes

Several equities research analysts have recently weighed in on LRCX shares. Jefferies Financial Group reiterated a “buy” rating and set a $200.00 target price (up from $175.00) on shares of Lam Research in a research note on Monday, December 15th. Wells Fargo & Company increased their price objective on Lam Research from $250.00 to $290.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Weiss Ratings reiterated a “buy (b)” rating on shares of Lam Research in a research note on Monday, December 29th. KeyCorp reissued a “sector weight” rating on shares of Lam Research in a report on Thursday, January 29th. Finally, Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 20th. One investment analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average target price of $245.19.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.